News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
773,729 Results
Type
Article (52383)
Company Profile (302)
Press Release (721029)
Multimedia
Podcasts (138)
Webinars (21)
Section
Business (213569)
Career Advice (2198)
Deals (36881)
Drug Delivery (149)
Drug Development (84596)
Employer Resources (179)
FDA (17399)
Job Trends (15920)
News (362195)
Policy (35050)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2843)
Academic (1)
Accelerated approval (53)
ADA (45)
Adcomms (34)
Allergies (185)
Alliances (51910)
ALS (232)
Alzheimer's disease (1894)
Antibody-drug conjugate (ADC) (513)
Approvals (17818)
Artificial intelligence (750)
ASCO (338)
Autoimmune disease (341)
Automation (60)
Bankruptcy (377)
Best Places to Work (12110)
BIOSECURE Act (22)
Biosimilars (237)
Biotechnology (191)
Bladder cancer (203)
Brain cancer (78)
Breast cancer (809)
Cancer (6297)
Cardiovascular disease (521)
Career advice (1875)
Career pathing (49)
CAR-T (360)
CDC (66)
Celiac Disease (3)
Cell therapy (966)
Cervical cancer (54)
Clinical research (73545)
Collaboration (2241)
Company closure (5)
Compensation (1466)
Complete response letters (87)
COVID-19 (2936)
CRISPR (115)
C-suite (1233)
Cystic fibrosis (157)
Data (8526)
Decentralized trials (3)
Denatured (43)
Depression (180)
Dermatology (95)
Diabetes (665)
Diagnostics (7237)
Digital health (64)
Diversity (14)
Diversity, equity & inclusion (46)
Drug discovery (342)
Drug pricing (217)
Drug shortages (34)
Duchenne muscular dystrophy (303)
Earnings (94557)
Editorial (73)
Employer branding (22)
Employer resources (155)
Events (126106)
Executive appointments (1134)
FDA (21392)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (36)
Funding (1847)
Gene editing (248)
Generative AI (67)
Gene therapy (766)
GLP-1 (1171)
Government (5076)
Grass and pollen (6)
Guidances (417)
Healthcare (20262)
Hematology (194)
HIV (89)
Huntington's disease (60)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (110)
Immunology and inflammation (304)
Immuno-oncology (106)
Indications (205)
Infectious disease (3307)
Inflammatory bowel disease (228)
Inflation Reduction Act (14)
Influenza (141)
Intellectual property (313)
Interviews (350)
IPO (17093)
IRA (52)
Job creations (4112)
Job search strategy (1562)
JPM (64)
Kidney cancer (20)
Labor market (110)
Layoffs (612)
Leadership (43)
Legal (8540)
Liver cancer (107)
Longevity (35)
Lung cancer (852)
Lymphoma (457)
Machine learning (63)
Management (59)
Manufacturing (1127)
MASH (215)
Medical device (15020)
Medtech (15174)
Mergers & acquisitions (21072)
Metabolic disorders (1692)
mRNA (243)
Multiple sclerosis (198)
NASH (17)
Neurodegenerative disease (473)
Neuropsychiatric disorders (115)
Neuroscience (3549)
Neurotech (1)
NextGen: Class of 2026 (6957)
Non-profit (4804)
Now hiring (80)
Obesity (791)
Opinion (318)
Ovarian cancer (240)
Pain (268)
Pancreatic cancer (339)
Parkinson's disease (396)
Partnered (34)
Patents (624)
Patient recruitment (742)
Peanut (67)
People (62804)
Pharmaceutical (65)
Pharmacy benefit managers (34)
Phase 1 (22934)
Phase 2 (32352)
Phase 3 (24113)
Pipeline (9561)
Policy (344)
Postmarket research (2747)
Preclinical (9782)
Press Release (67)
Prostate cancer (335)
Psychedelics (63)
Radiopharmaceuticals (353)
Rare diseases (1172)
Real estate (6396)
Recruiting (72)
Regulatory (27237)
Reports (59)
Research institute (2599)
Resumes & cover letters (375)
Rett syndrome (41)
RNA editing (24)
RSV (91)
Schizophrenia (190)
Series A (307)
Series B (229)
Service/supplier (12)
Sickle cell disease (120)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (51)
Startups (3930)
State (2)
Stomach cancer (19)
Supply chain (136)
Tariffs (90)
The Weekly (93)
Vaccines (1206)
Venture capital (121)
Weight loss (526)
Women's health (136)
Worklife (21)
Date
Today (126)
Last 7 days (669)
Last 30 days (3210)
Last 365 days (31260)
2026 (15219)
2025 (31039)
2024 (36233)
2023 (41271)
2022 (52545)
2021 (57224)
2020 (56022)
2019 (48876)
2018 (36997)
2017 (33923)
2016 (33702)
2015 (39713)
2014 (33435)
2013 (28637)
2012 (30931)
2011 (31622)
2010 (29994)
Location
Africa (839)
Alabama (95)
Alaska (7)
Arizona (370)
Arkansas (16)
Asia (43397)
Australia (7176)
California (13934)
Canada (3911)
China (1518)
Colorado (607)
Connecticut (624)
Delaware (432)
Europe (94677)
Florida (2077)
Georgia (452)
Hawaii (3)
Idaho (67)
Illinois (1179)
India (94)
Indiana (631)
Iowa (23)
Japan (578)
Kansas (136)
Kentucky (52)
Louisiana (60)
Maine (76)
Maryland (1691)
Massachusetts (10062)
Michigan (385)
Minnesota (772)
Mississippi (7)
Missouri (150)
Montana (33)
Nebraska (29)
Nevada (152)
New Hampshire (90)
New Jersey (3677)
New Mexico (32)
New York (3654)
North Carolina (1834)
North Dakota (9)
Northern California (7011)
Ohio (418)
Oklahoma (24)
Oregon (42)
Pennsylvania (2780)
Puerto Rico (29)
Rhode Island (53)
South America (1220)
South Carolina (88)
South Dakota (2)
Southern California (5513)
Tennessee (225)
Texas (2248)
United States (49541)
Utah (413)
Vermont (1)
Virginia (337)
Washington D.C. (84)
Washington State (1139)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
773,729 Results for "bio2 medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OS Therapies to Attend Upcoming Medical, Financial and Industry Conferences
• ASCO 2026: 2.5-Year Overall Survival Data • Jefferies Healthcare Conference: Partnering & Investor meetings • BIO International Convention: Panel Participation • MIB Agents Factor Osteosarcoma Conference: Data Presentation
May 26, 2026
·
4 min read
Press Releases
INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models
April 16, 2026
·
5 min read
Press Releases
Novanta Inc. Announces Acquisition of Riverpoint Medical
June 9, 2026
·
12 min read
Press Releases
Formation Bio Doses First Participant in Phase 1 Trial of BLKR201, a CNS-Penetrant TYK2 Inhibitor
June 9, 2026
·
3 min read
Press Releases
INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
May 15, 2026
·
5 min read
Press Releases
Upstream Bio to Showcase Additional Efficacy Data from the Phase 2 VIBRANT Trial of Verekitug in CRSwNP in Oral Session at EAACI 2026
June 8, 2026
·
3 min read
Press Releases
Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378
June 9, 2026
·
3 min read
Press Releases
Oorja Bio Unveils Clinical Data for ORJ-001, a First-in-Class Therapeutic Targeting Alveolar Epithelial Type 2 (AEC2) Cells for Treatment of Idiopathic Pulmonary Fibrosis (IPF)
May 19, 2026
·
6 min read
Press Releases
Kelun-Biotech Partner Windward Bio Announces First Patients Dosed in Phase 2 SIRIUS COPD Study of SKB378/WIN378
June 9, 2026
·
4 min read
Press Releases
INmune Bio Reports Statistically Significant Treatment Effect on Advanced White Matter MRI Biomarker in Phase 2 MINDFuL Alzheimer’s Trial
June 2, 2026
·
10 min read
1 of 77,373
Next
